Aflibercept biosimilar 更新时间：2023-04-03 13:09:22 常用名 阿柏西普 CAS号 862111-32-8 价钱 $需询单/500mg $需询单/1g $需询单/2g $需询单/5g 纯度 98.0% 备货期 需询单 库存 现货 产物详情（用途，包装等） Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept biosimilar is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa. Aflibercept biosimilar is produced in recombinant Chinese hamster ovary (CHO) cells. Aflibercept biosimilar is supplied at a concentration of 40 mg/mL as a sterile, clear, and colorless to pale yellow solution, which contains 10 mM sodium phosphate, 40 mM sodium chloride, 0.03% polysorbate 20, and 5% sucrose, pH 6.2. 供应商信息 上海拓普韦尔生物医药科技有限公司 认证状态： 未认证供应商 电话： +86-02158180488 地址： Room 315, Building 3, No. 1666, Xinyang Highway, Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone 区域： China 联系人： Bruce 联系人电话： +86-21-58180488 邮件： sales@topwellpharma.com 网址： www.topwellpharma.com 主要市场： Europe and America